Possible Parkinson's drug 'shows potential'RSS Feed

A new drug has shown potential for treating the brain injury seen in Parkinson's disease, research has shown.

Research published in the Journal of Parkinson's Disease showed the drug to restore function in rodents with an animal model of the condition for extended periods.

Platelet-derived growth factor-BB (PDGF-BB) was seen to have promise as a clinical candidate of the drug for treatment of the condition.

Anders Haegerstrand, chief scientific officer of NeuroNova AB, concluded: "Based on the current data, we consider platelet-derived growth factor-BB a clinical candidate drug for treatment of Parkinson's disease."

This comes after a new study revealed that living and working in the vicinity of pesticides could lead to Parkinson's disease.

According to research published in the European Journal of Epidemiology, individuals who live near fields where fungicide maneb and herbicide paraquat are used have a 75 per cent higher risk of developing Parkinson's disease.

News from Serious Law, specialist spinal injury compensation solicitors

Posted by Paul Breen
 

Brain scan measures Alzheimer's traits in Down's syndrome patients

14 June 2011

Brain injury similar to that seen in Alzheimer's disease has been measured in adults with Down's syndrome, a new study has reported.Scientists at the University of California Los Angeles used a...

Read More...

3D brain consciousness imaging could guide injury treatment

13 June 2011

Scientists are hoping that they can better understand the consequences of brain injury through loss of consciousness using 3D technology.A 3D movie formed using sophisticated imaging equipment by researchers...

Read More...

MS risk enhanced by shingles, study shows

10 June 2011

Spinal and brain injury caused by multiple sclerosis may be triggered by shingles in some cases, researchers have suggested.A group of more than 300,000 adults in Taiwan with the herpes zoster virus were...

Read More...